advancing generic drug development: translating science to approval 2023 – day 2 – part 2
Published 11 months ago • 528 plays • Length 1:31:24Download video MP4
Download video MP3
Similar videos
-
7:58:37
advancing generic drugs development: translating science to approval 2023 - day 2
-
1:15:00
advancing generic drug development: translating science to approval 2023 – day 2 – part 3
-
1:38:58
advancing generic drug development: translating science to approval 2023 – day 2 – part 1
-
1:47:48
advancing generic drug development: translating science to approval – day 2 – session 5
-
1:50:00
advancing generic drug development: translating science to approval – day 2 – session 7
-
1:23:36
advancing generic drug development: translating science to approval 2023 – day 1 – part 1
-
7:01:55
advancing generic drug development: translating science to approval 2024 (day 2)
-
1:34:14
advancing generic drug development translating science to approval day 2–session 8 & closing remarks
-
1:54:55
advancing generic drug development: translating science to approval 2023 – day 2 – part 4
-
8:05:24
advancing generic drugs development: translating science to approval 2023 - day 1
-
6:06
advancing generic drug development: translating science to approval, day two closing remarks
-
1:45:11
advancing generic drug development: translating science to approval – day 2 – session 6
-
6:07
advancing generic drug development: translating science to approval, day one closing remarks
-
1:24:28
advancing generic drug development: translating science to approval 2023 – day 1 – part 2
-
7:12:31
advancing generic drug development: translating science to approval 2024 (day 1)
-
9:06
advancing generic drug development: translating science to approval keynote address
-
1:28:11
advancing generic drug development: translating science to approval 2023 – day 1 – part 3
-
2:20:41
advancing generic drug development: translating science to approval 2023 – day 1 – part 4
-
1:54:43
advancing generic drug development translating science to approval day 1–session 4 & closing remarks